Global Cannabis Applications Corp Pushes Blockchain Innovation on an Age-old Industry!

Rising-star organization GCAC combines the latest artificial intelligence technologies to drive legal cannabis to the next level.

When you hear the terms “cannabis” and the “blockchain,” the immediate reaction is to assume that the two are mutually exclusive. Often and unfairly maligned, cannabis is a botanical compound that has been used throughout human history for both medicinal and recreational uses. Blockchain, on the other hand, is a decentralized distributed ledger system. It has only existed for the last ten years.

Yet despite their lack of any apparent similarities, both are necessary for advancing the battle for individual civil liberties. Amid the noise of the 2016 U.S. general election was the fact that a record number of states voted for marijuana legalization, to varying degrees. Though a major victory, facilitating the path towards practical legalization is another matter. This is where Global Cannabis Applications Corp. (OTCQB: FUAPF) (CSE: APP) steps in.

As California clearly demonstrated, a substantial difference exists between ballot triumphs and actual execution. Although cannabis is technically legal in “The Golden State,” a minor detail was often ignored: the voter-approved bill allowed individual cities to regulate marijuana sales. Chaos and confusion quickly ensued.

In Palo Alto, cannabis products can be delivered to your door, but brick-and-mortar retail sales are illegal. In nearby neighboring cities, however, both retail sales and marijuana cultivation are fully legal. With such bureaucratic inefficiencies, a political victory could potentially be rendered a defeat.

California’s cannabis laws are making headlines, but they’re not the only locales to do so. Other states, indeed, a growing number of sovereign nations, are considering marijuana legalization. However, the transition from a restrictive policy to an open one requires significant skills and expertise.

Rather than re-invent the wheel, Global Cannabis Applications Corp. (GCAC) utilizes the emerging technologies of the blockchain and artificial intelligence to streamline policy execution. That is, GCAC effectively channels the administration of the marijuana industry, ensuring that policies are followed according to governmental standards.

In short, GCAC is a pioneer in the next-generation cannabis sector, one that will rely increasingly on today’s emerging technologies.


Global Cannabis Applications Corp.’s Impressive Fundamentals

Arguably, the most remarkable element within the blockchain architecture is the “trust validation.” Underlining all business transactions is trust. Traders trust that the markets will make good on their contracts. Consumers trust that retailers will sell them products in good faith that they’re free from fault or defects. Without trust, commerce would simply fail.

Prior to the blockchain, the concept of “internet currencies” was frequently suggested but never practically forwarded. A digital token could simply be replicated an infinite number of times, rendering a potential digital economy worthless. As a result, expensive and inefficient third-party intermediaries were required to ensure the validity of online transactions.

But what if the third-party intermediary itself could be replaced with an immutable source, such as a blockchain platform? In such a system, transactions could occur without the need of a third-party human operator, someone who is vulnerable to personal interests, corruption, or incompetence. The blockchain provides this extraordinary solution; hence, its dramatic, headline-grabbing surge.

The true beauty of the blockchain, though, goes far beyond confirming financial transactions. It directly and positively impacts industries where the trust concept is either compromised or otherwise lacking.

One of the biggest impediments towards universal marijuana legalization is data validity. Without any shred of doubt, the cannabis plant has been instrumental in offering alternative therapies and medicinal solutions. Unfortunately, without a clear, consistent, and trusted database, any collected medical information aligned with cannabis therapies is often disregarded as spurious.

Global Cannabis Applications intends to change the way we collect, analyze, store and use large scale and complex data sets that relate to medical cannabis use as therapy. Utilizing the GCAC mobile application, each member of the medicinal cannabis community — from suppliers, researchers, retailers, dispensaries, clinicians, patients and regulators — can input and receive information associated with cannabis therapies. The information is then structured and stored in a multi-variate user oriented database, from which proprietary artificial intelligence analytic software can make rational predictions regarding unexpected efficacy patterns of various cannabinoid combinations and profiles.  This data is expected to prove as highly valuable for the pharmaceutical industry developing novel cannabinoid based therapeutics and for the general patient populations that consume medical cannabis to treat various indications.

GCAC’s technology-based approach is substantially different from prior methodologies in that precise cannabis compounds and compound combinations that impact certain ailments can be identified.  Such novel insights can be derived from deep learning algorithms that digest massive amounts of patient data, even though they are usually invisible in the sporadic, limited data that is available to us today in the cannabis space.

To promote a robust marketplace for the creation and consumption of medicinal cannabis data extracted from highly-vetted sources, GCAC utilizes cryptocurrencies. Not only does this technology facilitate data trade and transactions, it catalyzes a dynamic, digital economy featuring a 360-degree exchange platform. This control, transparency and commerciality will encourage data sharing amongst participants for better product and treatment outcomes. Such medicinal data information economy is truly transformational for the medicinal cannabis industry.

To ensure the highest level of trust, all database entries are confirmed through the blockchain. This rigorous system prevents faulty or artificially manufactured information from corrupting the registry. Furthermore, government bodies, as well as the medical community, have in their hands a perfect record of how the information was collected, stored, and disseminated.

The GCAC blockchain, as a completely transparent network, cannot lie. This is in sharp contrast to the traditional pharmaceutical industry, which relies on a host of human administrators. As you can see from recent controversies, many of these supposedly trusted administrators were eventually found corruptible.

The blockchain inherently prevents that corruption from occurring, thus giving Global Cannabis Applications a substantive advantage in the marketplace.


Robust Investment Potential for GCAC

From an investor’s perspective, the broader technology sector comes with an inherent risk; namely, that up-and-coming tech stocks are a dime a dozen. Daily, our inboxes are filled with opportunities from every shade of the industry’s spectrum. What makes GCAC and its underlining FUAPF stock stand out?

Primarily, the blockchain concept — though very much proven across a variety of applications – is still considered an emerging technology. While the blockchain’s popular derivative offshoots, cryptocurrencies, are making major headlines, a substantial number of Americans question their legality. This remarkable confusion is a direct indicator that the blockchain is still near its infancy stage.

Why is this critical? Consider that GCAC is a pioneer within an already pioneering industry. Inevitably, the general public will eventually recognize the blockchain’s native superiority over all other commerce and business platforms. Waves of investment dollars will trickle into companies that have established a proven base with the blockchain platform. In this context, GCAC is well ahead of the curve.

Another factor to bear in mind is timing. The best gains are never made jumping onboard the bandwagon. Rather, early-bird investors, or those that recognize an opportunity ahead of the bandwagon, stand to profit the most.

Unfortunately, in this current age, we have few paradigm-altering investments. Sectors that were once considered groundbreaking, such as e-commerce and internet companies, are today duking it out in saturated markets. There’s only so many ways you can produce a smartphone or a flat-screen TV. In other words, most advancements from yesteryear have become commoditized.

You cannot say the same thing about Global Cannabis Applications. As previously discussed, multiple states and nations are embarking on an unprecedented legal journey. In turn, they need an unprecedented technology to guide them through what would otherwise be a volatile and chaotic transition.

This is the key opportunity that is behind every share of FUAPF stock. Backed by a dedicated team of experts with multiple years of experience, GCAC aims to simplify the complex procedures and political channels involved in marijuana legalization. In doing so, they open doors to new avenues of medical research and revenue generation that were previously unattainable.


The Cannabis Investor is always researching new trade ideas which have the makings for large market moves. Traders are urged to follow our parent outlet, The Wealthy Venture Capitalist & The Cannabis Investor, on social media (see below) to stay apprised. We are an anti-email media outlet, and as such will only be releasing our reports/ updates/ news through Twitter and Facebook, as well as newswire.



Join the largest Cannabis Investing page on Facebook:

To receive text Message alerts when new articles are released click here:

Join our Email list:

Follow us on Twitter: @CannaInvestor
Like us on



This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below. The Wealthy Venture Capitalist and its employees are not a Registered Investment Advisors, Broker Dealers or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Sometimes human error can attribute to honest mistakes in reporting on issues regarding public companies and overall capital markets, and as such we are not responsible for the complete accuracy in these reports as the reader is required to verify all statements to ensure they are completely accurate. The Wealthy Venture Capitalist’s controlling parent company has been compensated $39,500 per month for 3 months by Global Cannabis Applications Corp. The Wealthy Venture Capitalist’s controlling parent company holds a restricted position in Global Cannabis Applications Corp (FUAPF) (APP).  The Wealthy Venture Capitalist encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources and The Wealthy Venture Capitalist makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects,” “foresee,” “expects,” “will,” “anticipates,” “estimates,” “believes,” “understands,” or that by statements indicating certain actions “may,” “could,” or “might” occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security’s previous day closing price and the high of day price during our promotional coverage. Readers must visit our website at in order to view our entire disclaimer which covers most of the risks, biases and liability releases to have a full understanding after reading this article.

Leave a Reply

Your email address will not be published. Required fields are marked *

pour la musculation tamoxifen buylivraison anonyme, prix favorable As a rule, the infection occurs during penetrative sexual intercourse buy metronidazole no prescription moist environment and can remain viable. cialis 20mg rezeptfreider Wirkstoff des Arzneimittels wird nicht verlassen, Zweifel an der Wirksamkeit der Pillen ein bewährtes Medikament zur Behandlung von BPH in einer Dosierung von 10 mg, die Möglichkeit gibt, ein neues Potential des Penis, um zu versuchen buy Retin AThis drug will no doubt help to solve the problem with acne in young people from 16 years, thanks to the active ingredient of this cream you will experience relief, people will stop laughing at you Diagnosticare la causa della disfunzione erettilecomprar cilaiscosì spesso il trattamento può comportare molteplici tecniche. Comprar cialis en línea

Wealthy Venture Capitalist